Skip to main content
. Author manuscript; available in PMC: 2019 Oct 28.
Published in final edited form as: J Control Release. 2018 Sep 14;288:212–226. doi: 10.1016/j.jconrel.2018.09.011

Table 3.

Pharmacokinetic Parameters of DOX in Different Formulations.

Groups T1/2(h) AUC0−∞ (μg/ml*h) Cmax (μg/µL) CL (µL/h) Vd (µL)

DOX.HCl 3.35 9.20 4.41 10.87 52.49

POEG-b-POM/DOX 15.96 84.31 21.30 1.19 27.31
POEG-b PPPMP/DOX 16.19 180.16 27.60 0.56 12.97